BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16799475)

  • 1. Expression of p14ARF, p15INK4b, p16INK4a, and DCR2 increases during prostate cancer progression.
    Zhang Z; Rosen DG; Yao JL; Huang J; Liu J
    Mod Pathol; 2006 Oct; 19(10):1339-43. PubMed ID: 16799475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of p14ARF, p15INK4b, and p16INK4a inactivation in malignant peripheral nerve sheath tumors.
    Endo M; Kobayashi C; Setsu N; Takahashi Y; Kohashi K; Yamamoto H; Tamiya S; Matsuda S; Iwamoto Y; Tsuneyoshi M; Oda Y
    Clin Cancer Res; 2011 Jun; 17(11):3771-82. PubMed ID: 21262917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
    Pare R; Shin JS; Lee CS
    Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma.
    Feng W; Xiao J; Zhang Z; Rosen DG; Brown RE; Liu J; Duan X
    Mod Pathol; 2007 Sep; 20(9):961-6. PubMed ID: 17632454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course.
    Watanabe T; Katayama Y; Yoshino A; Komine C; Yokoyama T
    Clin Cancer Res; 2003 Oct; 9(13):4884-90. PubMed ID: 14581362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status.
    Chaussade L; Eymin B; Brambilla E; Gazzeri S
    Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque.
    Holdt LM; Sass K; Gäbel G; Bergert H; Thiery J; Teupser D
    Atherosclerosis; 2011 Feb; 214(2):264-70. PubMed ID: 20637465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferentially different mechanisms of inactivation of 9p21 gene cluster in liver fluke-related cholangiocarcinoma.
    Chinnasri P; Pairojkul C; Jearanaikoon P; Sripa B; Bhudhisawasdi V; Tantimavanich S; Limpaiboon T
    Hum Pathol; 2009 Jun; 40(6):817-26. PubMed ID: 19200577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of the p14(ARF), p15(INK4B) and p16(INK4A) genes is a frequent event in human oral squamous cell carcinomas.
    Shintani S; Nakahara Y; Mihara M; Ueyama Y; Matsumura T
    Oral Oncol; 2001 Sep; 37(6):498-504. PubMed ID: 11435176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p16 is a major inactivation target in hepatocellular carcinoma.
    Jin M; Piao Z; Kim NG; Park C; Shin EC; Park JH; Jung HJ; Kim CG; Kim H
    Cancer; 2000 Jul; 89(1):60-8. PubMed ID: 10897001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
    Kanellou P; Zaravinos A; Zioga M; Spandidos DA
    Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant methylation of p14(ARF), p15(INK4b) and p16(INK4a) genes and location of the primary site in pulmonary squamous cell carcinoma.
    Furonaka O; Takeshima Y; Awaya H; Ishida H; Kohno N; Inai K
    Pathol Int; 2004 Aug; 54(8):549-55. PubMed ID: 15260845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancer of zeste homolog 2 depletion induces cellular senescence via histone demethylation along the INK4/ARF locus.
    Jie B; Weilong C; Ming C; Fei X; Xinghua L; Junhua C; Guobin W; Kaixiong T; Xiaoming S
    Int J Biochem Cell Biol; 2015 Aug; 65():104-12. PubMed ID: 26004298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations of INK4a(p16-p14ARF)/INK4b(p15) expression and telomerase activation in meningioma progression.
    Simon M; Park TW; Köster G; Mahlberg R; Hackenbroch M; Boström J; Löning T; Schramm J
    J Neurooncol; 2001 Dec; 55(3):149-58. PubMed ID: 11859969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ; Chen KM; Tiwari N; Pals G; Schouten JP; Sethi S; Benninger MS
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bmi1 promotes prostate tumorigenesis via inhibiting p16(INK4A) and p14(ARF) expression.
    Fan C; He L; Kapoor A; Gillis A; Rybak AP; Cutz JC; Tang D
    Biochim Biophys Acta; 2008 Nov; 1782(11):642-8. PubMed ID: 18817867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of p14(ARF), p15(INK4b), p16(INK4a) and skp2 increases during esophageal squamous cell cancer progression.
    Bai P; Xiao X; Zou J; Cui L; Bui Nguyen TM; Liu J; Xiao J; Chang B; Wu J; Wang H
    Exp Ther Med; 2012 Jun; 3(6):1026-1032. PubMed ID: 22970012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiles of the 2 INK4a gene products, p16 and p14ARF, in human reference urothelium and bladder carcinomas, according to pRb and p53 protein status.
    Le Frère-Belda MA; Gil Diez de Medina S; Daher A; Martin N; Albaud B; Heudes D; Abbou CC; Thiery JP; Zafrani ES; Radvanyi F; Chopin D
    Hum Pathol; 2004 Jul; 35(7):817-24. PubMed ID: 15257544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.
    Faderl S; Kantarjian HM; Estey E; Manshouri T; Chan CY; Rahman Elsaied A; Kornblau SM; Cortes J; Thomas DA; Pierce S; Keating MJ; Estrov Z; Albitar M
    Cancer; 2000 Nov; 89(9):1976-82. PubMed ID: 11064355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.